Petmed Express Inc (PETS) Financial Statements
Industry: Drug Stores and Proprietary Stores (Retail)
In fiscal 2026, Petmed Express reported revenue of $179.0M, down 21.1% from $227.0M the year before. Net income was -$57.3M (a -32.0% net margin), or -$2.74 per diluted share. Gross margin was 28.1% and operating margin was -32.8%. Operating activities generated -$28.4M of cash, leaving -$33.0M of free cash flow. At fiscal year end, Petmed Express held $81.2M in total assets against $52.3M in total liabilities, including $21.4M of cash and equivalents.
Open the full interactive Petmed Express financials → Quarterly statements, key ratios, valuation history and price charts.
Petmed Express Key Stats
| Share Price | $1.27 |
|---|---|
| Market Cap | $27.5M |
| Revenue YoY Growth | -21.1% |
| 52-Week Range | $1.26 – $3.90 |
| Shares Outstanding | 21.7 million (basic, 2027 Q1) |
Petmed Express Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $309.2M | $273.4M | $256.9M | $281.1M | $227.0M | $179.0M |
| Cost of Goods Sold | $219.3M | $195.3M | $185.8M | $202.4M | $157.8M | — |
| Gross Profit | $89.9M | $78.1M | $71.0M | $78.6M | $69.1M | $50.2M |
| Operating Income | $37.6M | $25.7M | -$1.4M | -$8.2M | -$1.5M | -$58.7M |
| Pre-Tax Income | $39.2M | $27.1M | $1.6M | -$6.3M | -$587,000 | -$57.4M |
| Income Tax | $8.6M | $6.0M | $1.4M | $1.2M | $5.7M | -$73,000 |
| Net Income | $30.6M | $21.1M | $233,000 | -$7.5M | -$6.3M | -$57.3M |
| Diluted EPS | $1.52 | $1.04 | $0.01 | -$0.37 | -$0.30 | -$2.74 |
Petmed Express Quarterly Results
| 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | |
|---|---|---|---|---|
| Revenue | $44.4M | $40.7M | $42.8M | $41.0M |
| Net Income | -$8.5M | -$10.6M | -$4.1M | -$6.1M |
| Diluted EPS | -$0.41 | -$0.50 | -$0.19 | -$0.28 |
Petmed Express Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $118.7M | $111.1M | $104.1M | $55.3M | $54.7M | $21.4M |
| Current Assets | $161.2M | $151.0M | $131.5M | $93.6M | $78.9M | $43.6M |
| Total Assets | $187.5M | $176.3M | $164.1M | $169.9M | $148.7M | $81.2M |
| Current Liabilities | $44.9M | $33.2M | $36.5M | $72.2M | $62.8M | $52.0M |
| Total Liabilities | $46.2M | $34.1M | $40.3M | $73.2M | $63.6M | $52.3M |
| Shareholders' Equity | $141.3M | $142.2M | $123.8M | $96.7M | $85.1M | $28.9M |
Petmed Express Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $40.1M | $18.5M | $27.8M | $4.3M | $4.7M | -$28.4M |
| Cash From Investing | -$2.4M | -$1.8M | -$10.3M | -$40.7M | -$5.1M | -$4.6M |
| Cash From Financing | -$22.7M | -$24.4M | -$24.5M | -$12.4M | -$181,000 | -$299,000 |
| Free Cash Flow | $37.6M | $16.7M | $22.5M | -$194,000 | -$395,000 | -$33.0M |
Figures from Petmed Express' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Petmed Express financials page for every line item.
Petmed Express Company Profile
| Ticker | PETS |
|---|---|
| Exchange | Nasdaq |
| Industry | Drug Stores and Proprietary Stores (Retail) |
| Headquarters | Delray Beach, Florida |
| Incorporated in | Florida |
| Fiscal Year End | March 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001040130 |
Frequently Asked Questions
What was Petmed Express' revenue in fiscal 2026?
Petmed Express (PETS) reported revenue of $179.0M for fiscal 2026.
What is Petmed Express' annual revenue history?
Petmed Express' annual revenue by fiscal year: 2021: $309.2M; 2022: $273.4M; 2023: $256.9M; 2024: $281.1M; 2025: $227.0M; 2026: $179.0M.
What was Petmed Express' net income in fiscal 2026?
Petmed Express reported net income of -$57.3M for fiscal 2026.
What was Petmed Express' earnings per share (EPS) in fiscal 2026?
Petmed Express' diluted EPS was -$2.74 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Petmed Express generate in fiscal 2026?
Petmed Express generated -$33.0M of free cash flow in fiscal 2026.
What was Petmed Express' revenue last quarter?
In its most recent reported quarter (2027 Q1), Petmed Express reported revenue of $41.0M.
How many shares of Petmed Express are outstanding?
Petmed Express reported a weighted average of 21.7 million basic shares outstanding in 2027 Q1.
What is Petmed Express' market cap?
Based on its latest closing price, Petmed Express (PETS) has a market capitalization of about $27.5M.
When does Petmed Express' fiscal year end?
Petmed Express' fiscal year end, as registered with the SEC, is March 31.
Where is Petmed Express headquartered?
Petmed Express lists its business address in Delray Beach, Florida in its SEC filings.